Reports Library Publication
Insight Consumer Healthcare Latin America March / April 2026
30th April 2026 by CHC Insight
1. GIs Brazil shines with PPI, antinauseant actives now OTC; Mexico declines
2. ILAR Study LatAm’s first study into the link between health literacy and self-care
3. DB6 A round-up of the activity driving 2025 LatAm CHC growth +6.7%
4. Innovation Round-up Nestlé selects Brazil as the pilot market for Vital supplements range
5. News Review EMS grows in generics with Medley; Elea gains stake in Cellera Farma
Order this report
Why buy this report?
"The latest update from DB6 shows that value retail sales of LatAm’s CHC market expanded by 6.7% in 2025, down from a healthier 10.4% in 2024 (see Feature, p28). GIs was the weakest major category, managing growth of just 2.9% as largest subcategory ORTs turned negative. This resulted from a downturn in Mexico, where the subcategory peaked in 2023 (+12.9%) but has since faced competition from beverage launches from PepsiCo and Coca-Cola, while a new tax framework from 2026 is set to impact the pricing environment. In contrast, ORTs had another strong year in Brazil, where marketers are seeking to gain scale via expansion in non-pharmacy channels and are exploring differentiated formats and formulas. "
Nicholas Hall